What were Fischer Medical Ventures Ltd's latest quarterly results?
Fischer Medical Ventures Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -642.0%
- Revenue Growth YoY: +98.8%
- Operating Margin: 1.0%
Fischer Medical Ventures Ltd: Stock Analysis & Fundamentals
Updated this weekFischer Medical Ventures Ltd (Chemicals - Inorganic) — fundamental analysis, earnings data, and key metrics. PE: 78.0. ROE: 8.6%. This stock is not currently in the Nifty 500 momentum outperformers list.
Fischer Medical Ventures Ltd Key Facts
What's Happening
💪Debt reduced 72% YoY — balance sheet strengthening
👔Promoter stake down 13.1% this quarter
🌐FII stake increased 0.5% this quarter
Key Numbers
Current Price
₹37
Dividend Yield
0.01%
Market Cap
2.4K Cr
Valuation
N/AOther Top Chemicals - Inorganic Stocks Beating Nifty 500
Frequently Asked Questions: Fischer Medical Ventures Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Fischer Medical Ventures Ltd's current PE ratio?
Fischer Medical Ventures Ltd's current PE ratio is 78.0x.
- Current PE: 78.0x
- Market Cap: 2.4K Cr
- Dividend Yield: 0.01%
What is Fischer Medical Ventures Ltd's price-to-book ratio?
Fischer Medical Ventures Ltd's price-to-book ratio is 6.3x.
- Price-to-Book (P/B): 6.3x
- Book Value per Share: ₹6
- Current Price: ₹37
Is Fischer Medical Ventures Ltd a fundamentally strong company?
Fischer Medical Ventures Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 11.0%
Is Fischer Medical Ventures Ltd debt free?
Fischer Medical Ventures Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹107 Cr
What is Fischer Medical Ventures Ltd's return on equity (ROE) and ROCE?
Fischer Medical Ventures Ltd's return ratios over recent years
- FY2024: ROCE 5.0%
- FY2025: ROCE 1.0%
- FY2026: ROCE 11.0%
Is Fischer Medical Ventures Ltd's cash flow positive?
Fischer Medical Ventures Ltd's operating cash flow is negative (FY2026).
- Cash from Operations (CFO): ₹-101 Cr
- Free Cash Flow (FCF): ₹-106 Cr
- CFO/PAT Ratio: -326% (weak cash conversion)
What is Fischer Medical Ventures Ltd's dividend yield?
Fischer Medical Ventures Ltd's current dividend yield is 0.01%.
- Dividend Yield: 0.01%
- Current Price: ₹37
Who holds Fischer Medical Ventures Ltd shares — promoters, FII, DII?
Fischer Medical Ventures Ltd's shareholding pattern (Mar 2026)
- Promoters: 62.1%
- FII (Foreign): 5.0%
- DII (Domestic): 1.4%
- Public: 31.5%
Is promoter holding increasing or decreasing in Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd's promoter holding has increased recently.
- Current Promoter Holding: 62.1% (Mar 2026)
- Previous Quarter: 61.8% (Dec 2025)
- Change: +0.35% (increasing — positive signal)
Is Fischer Medical Ventures Ltd a new momentum entry or an established outperformer?
Fischer Medical Ventures Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Fischer Medical Ventures Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Fischer Medical Ventures Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd investment thesis summary:
What is the future outlook for Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.